Urothelial Carcinoma Recurrent

Also known as: Recurrent Urothelial Carcinoma / Transitional cell carcinoma recurrent

DrugDrug NameDrug Description
DB12768BCG vaccineA vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer.
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08875Cabozantinib1Active Not Recruiting1
DB13007Enfortumab vedotin1Recruiting1
DB12147Erdafitinib1Recruiting1
DB00441Gemcitabine1Recruiting1
DB00724Imiquimod1Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB15632Zalifrelimab1Recruiting1
DB08871Eribulin1 / 2Active Not Recruiting1
DB11714Durvalumab2Not Yet Recruiting1
DB09035Nivolumab2Recruiting1
DB15102Pemigatinib2Recruiting1
DB14851Relatlimab2Recruiting1
DB15310Vactosertib2Not Yet Recruiting1
DB12768BCG vaccine3Not Yet Recruiting1
DB16648Bacillus calmette-guerin substrain russian BCG-I live antigen3Not Yet Recruiting1
DB10343Bacillus calmette-guerin substrain tice live antigen3Not Yet Recruiting1
DB00305MitomycinNot AvailableAvailable1
DB00305MitomycinNot AvailableRecruiting1